[1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005; 352:1223-36.10.1056/NEJMra041536]Search in Google Scholar
[2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19:41-7.10.1093/humrep/deh098]Search in Google Scholar
[3. Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol. 2001; 98:325-31.]Search in Google Scholar
[4. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006; 20:235-44.10.1016/j.beem.2006.03.005]Open DOISearch in Google Scholar
[5. Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, et al. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol. 2006; 127:218-21.10.1016/j.ejogrb.2006.01.023]Search in Google Scholar
[6. Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med. 2008; 26:62-71.10.1055/s-2007-992926]Open DOISearch in Google Scholar
[7. Ozdemir S, Gorkemli H, Gezginc K, Ozdemir M, Kiyici A. Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2008; 103:44-9.10.1016/j.ijgo.2008.05.017]Search in Google Scholar
[8. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002; 81:799-816.10.1034/j.1600-0412.2001.810902.x]Search in Google Scholar
[9. Bennett GL, Andreotti RF, Lee SI, Dejesus Allison SO, Brown DL, Dubinsky T, et al. ACR appropriateness criteria on abnormal vaginal bleeding. J Am Coll Radiol. 2011; 8:460-8.10.1016/j.jacr.2011.03.011]Open DOISearch in Google Scholar
[10. Wongwananuruk T, Indhavivadhana S, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, et al. Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital. J Med Assoc Thai. 2010; 93: 399-405.]Search in Google Scholar
[11. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140:815-30.10.1016/0002-9378(81)90746-8]Search in Google Scholar
[12. Speroff L, Fritz MA. Amenorrhea. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams&Wikins; 2005.]Search in Google Scholar
[13. World Health Organization. Laboratory diagnosis and monitoring of diabetes mellitus. WHO 2002. Geneva:1-26.]Search in Google Scholar
[14. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998; 83:2694-8.10.1210/jc.83.8.2694]Search in Google Scholar
[15. Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A. Assessment of insulin resistance in young women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2008; 102:137-40.10.1016/j.ijgo.2008.03.017]Search in Google Scholar
[16. Sengos C, Andreakos C, Iatrakis G. Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2000; 27:35-8.]Search in Google Scholar
[17. Maiorano E, Loverro G, Viale G, Giannini T, Napoli A, Perlino E. Insulin-like growth factor-I expression in normal and diseased endometrium. Int J Cancer. 1999; 80:188-93.10.1002/(SICI)1097-0215(19990118)80:2<188::AID-IJC5>3.0.CO;2-E]Search in Google Scholar
[18. Speroff L, Fritz MA. Hirsutism. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams & Wikins; 2005.]Search in Google Scholar
[19. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2008; 15:485-97.10.1677/ERC-07-0064]Open DOISearch in Google Scholar
[20. Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008; 630:148-65.10.1007/978-0-387-78818-0_10]Search in Google Scholar
[21. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002; 11:1531-43.]Search in Google Scholar
[22. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 2004; 108: 425-32.10.1002/ijc.11529]Search in Google Scholar
[23. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006; 91:4237-45.10.1210/jc.2006-0178]Search in Google Scholar